文献速递产科母胎医学

1小时口服葡萄糖耐量试验前空腹与进食及口服摄入的比较:一项随机对照试验

Fasting Compared With Fed and Oral Intake Before the 1-Hour Oral Glucose Tolerance Test: A Randomized Controlled Trial.
PubMed 文献 · Obstet Gynecol · 2022-11-30

该单中心前瞻性随机试验将200名孕妇随机分为空腹6小时以上组与2小时内口服摄入组,在孕24周后行50g 1小时口服葡萄糖耐量试验。空腹组筛查阳性率显著高于进食组(32.0% vs 13.3%,P=.002),平均血糖值亦显著更高(127.7 mg/dL vs 113.3 mg/dL,P=.002),妊娠期糖尿病发生率两组差异未达统计学显著(12.4% vs 5.1%,P=.08)。

要点

  • 空腹6小时以上组1小时口服葡萄糖耐量试验筛查阳性率显著高于2小时内进食组(32.0% vs 13.3%,P=.002)。
  • 空腹组平均1小时血糖值显著高于进食组(127.7 mg/dL vs 113.3 mg/dL,P=.002)。
  • 两组妊娠期糖尿病发生率差异未达统计学显著(12.4% vs 5.1%,P=.08),母儿结局无显著差异。

核心结论

  • 与试验前2小时内进食相比,空腹6小时以上使1小时口服葡萄糖耐量试验阳性结果的发生率增加一倍。

研究设计与样本

  • 单中心、前瞻性随机试验,计划每组纳入100名参与者,从2020年11月至2021年4月共随机分配200名参与者。
  • 参与者随机分为空腹6小时以上组或2小时内口服摄入(进食)组,在孕24周后行50g 1小时口服葡萄糖耐量试验。
  • 筛查阳性定义为血清葡萄糖水平≥140 mg/dL,方案依从性通过口服葡萄糖耐量试验后立即进行的调查评估。
  • 195名参与者完成1小时口服葡萄糖耐量试验(空腹组97名,进食组98名)。

主要发现

  • 参与者调查确认空腹组依从率为97.9%(n=95),进食组依从率为91.8%(n=90)。
  • 空腹组筛查阳性率显著高于进食组(32.0% vs 13.3%,P=.002)。
  • 空腹组平均1小时血糖值显著高于进食组(127.7 mg/dL vs 113.3 mg/dL,P=.002)。
  • 空腹组妊娠期糖尿病发生率为12.4%(n=12),进食组为5.1%(n=5)(P=.08)。
  • 母儿结局无显著差异。

关键数值与推荐

  • 筛查阳性标准为血清葡萄糖水平≥140 mg/dL。
  • 空腹定义为空腹6小时以上,进食定义为试验前2小时内口服摄入。
  • 样本量计算假设空腹组筛查阳性率45%、进食组25%,检出20个百分点或以上的绝对差异,脱落率10%,双侧α=0.05,把握度0.8。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the effect of fasting compared with eating before the 1-hour oral glucose tolerance test (OGTT) on gestational diabetes mellitus (GDM) screening results. METHODS: In a single-center, prospective randomized trial, participants were randomized to: 1) fasting for 6 or more hours or 2) oral intake ("fed") within 2 hours of the 50-g, 1-hour OGTT. The 1-hour OGTT was administered after 24 weeks of gestation. A positive screen result was defined as a serum glucose level of 140 mg/dL or higher. Protocol adherence was assessed by a survey administered immediately after the OGTT. We planned to enroll 100 participants in each group to detect an absolute difference of 20 percentage points or more on the 1-hour OGTT screen-positive rate using Fisher exact test, assuming an estimated screen-positive rate of 45% in the fasting and 25% in the fed group and 10% attrition, with a two-sided α=0.05, power=0.8. The primary outcome was the 1-hour OGTT screen-positive rate. Secondary outcomes included mean 1-hour OGTT glucose values, GDM diagnosis, maternal and neonatal outcomes, and patient perceptions regarding the 1-hour OGTT. RESULTS: From November 2020 through April 2021, 200 participants were randomized. One hundred ninety-five completed the 1-hour OGTT (97 fasting, 98 fed). Participant surveys confirmed 97.9% (n=95) adherence to the fasting and 91.8% (n=90) adherence to the fed groups. The screen-positive rate was significantly higher in the fasting than the fed group (32.0% vs 13.3%, respectively, P=.002), as was the mean glucose value (127.7 mg/dL vs 113.3 mg/dL, P=.002). The incidence of GDM in the fasting group was 12.4% (n=12) and in the fed group was 5.1% (n=5) (P=.08). There were no significant differences in maternal or neonatal outcomes. CONCLUSION: Fasting for 6 or more hours doubled the incidence of a positive 1-hour OGTT result when compared with eating within 2 hours of the test. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov, NCT04547023.

来源:Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Sperling MM, Leonard SA, Miller SE, et al. Fasting Compared With Fed and Oral Intake Before the 1-Hour Oral Glucose Tolerance Test: A Randomized Controlled Trial. Obstet Gynecol. 2022. PMID: 36701613. doi:10.1097/AOG.0000000000005013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。